THE great increase in the use of beryllium compounds in the last fifteen years in the United States has resulted in the appearance of variable syndromes having, as I hope to prove, a basic pattern. For reasons of clarity, I shall speak of the pathological effect of incriminated beryllium exposures as beryllium poisoning, modifying this title as needed to indicate clinical syndromes.
Within limits depending more on the quantitative than the qualitative beryllium exposure, the worker may suffer an acute, subacute or chronic form of the disease.
Acute.-Gross exposure produces in a fairly high number of non-protected workers contact dermatitis, conjunctivitis, upper respiratory tract irritation and, in a smaller number, bronchitis and pneumonitis. If the lower respiratory tract is involved, weight loss, cyanosis, dyspnoea, drop in vital capacity are abruptly noted. Treatment consists of complete bed rest, administration of adequate amounts of oxygen and prolonged convalescence up to four and six months. Before the seriousness of beryllium pneumonia was recognised several patients died as a result of return of pulmonary oedema consequent onr early ambulation (Van Ordstrand, Hughes, De Nardi and Carmody, 1945) . Treated with rest, the pathological changes shown on the chest X-ray clear up, demonstrating the complete reversal of acute beryllium pneumonia. This clearing may take six months or longer. Similar episodes but of a much milder X-ray and clinical character are noted, requiring, however, in some instances as long as a year for complete clearing (Aub and .
Subacute.-An intermediate clinical syndrome of subacute illness is encountered in which there is a clear story of beryllium exposure. Beryllium can be detected in the urine (Cholak and Hubbard, 1948) , the X-ray picture shows fine nodularities in both lung fields, but the patient, while losing weight and suffering mild dyspncea and easy fatigue, is able to continue at some type of work.
Chronic.-Chronic beryllium poisoning has been designated because of outstanding pulmonary affections as delayed chemical pneumonitis. At the Saranac Symposium 1947 (Vorwald, 1950) it was designated "pulmonary granulomatosis of beryllium workers", a term which, in my opinion, is too narrow, as it refers to one histopathological phase and serves the clinician not at all.
In many cases, symptoms arise after apparently fantastically low-level exposures, varying in length of time from two weeks to several years of steady beryllium exposure and in a few instances after intermittent laboratory exposure. In analysing our data, we find that concurrently with fairly heavy exposure, a few non-protected fluorescent lamp manufacturing workers developed the chronic disease. In the majority of cases, however, a period of delay varying from a matter of a few months up to nine years has elapsed between cessation of beryllium exposure and onset of symptoms. Since we are discovering new cases, the possible period of delay is unknown. Very often a precipitating medical episode appears decisive-an infection, pregnancy or thyroid dysfunction. The patients uniformly complain of weight loss which may be profound.
Loss of weight, asthenia, dyspnoea on effort progressing to orthopncea, cough and later bouts of gastro-intestinal disturbances are usual complaints. Punch biopsy of the liver (Fig. 1 ) confirms the existence of beryllium hepatitis, with pathological picture similar to that seen in autopsied cases, and beryllium present in the tissue. The lung involvement is bilateral, apex to base in distribution, causing hilar lymphadenopathy, sometimes to a remarkable degree; marked emphysematous changes and spontaneous pneumothorax may occur.
FIG. 1.-Liver puncture: case of chronic beryllium poisoning.
As might be expected in long-standing extensive pulmonary disease, the electrocardiogram in a number of cases shows evidence of right ventricular enlargement, the oxygen saturation of the blood is lowered and especially in men a secondary polycythiemia frequently develops. Skin tuberculin tests have been positive in about the same proporfion as in the general population. Renal calculi have occurred in ambulatory as well as bed patients, in nearly one-fifth of the cases. Hypercalcoemia was a notable feature of metabolic studies done by Dr. William S. McCann's group at the Strong Memorial Hospital at Rochester. This group also found that patients with chronic beryllium disease are in negative nitrogen balance, which has considerable bearing on the great wasting in this disease. The 17-ketosteroid level in the urine is low as in many chronic illnesses and occasionally judicious use of testosterone has increased vigour and weight.
Death in chronic beryllium poisoning takes place in about 20 % of the cases. Right-sided heart failure, cerebral anoxia, intercurrent respiratory infection and, in a few cases, overwhelming inanition and profound cachexia are recorded as terminal episodes.
Chronic beryllium poisoning is in most diagnosed cases a serious disease of long duration with a poor prognosis, going through periods of remission and exacerbation. The small but definite group who have severe bouts of hyperpyrexia make one wonder if the beryllium stored in the tissues has somehow become mobile to cause this reaction. A worker-patient only rarely returns to work, and those few who do have little endurance, complain of dyspncea on effort or with slightest respiratory infections. The asymptomatic group contains at present, to my certain knowledge, a small number of workers-less than ten-with clear history of chronic exposure to beryllium compounds known to produce disease who have widespread chest X-ray changes in the lung fields and are excreting beryllium in the urine but are without complaints. The group characterized earlier as having what may be called subacute beryllium disease have signs and symptoms of beryllium poisoning but are able to do some work.
There is one important course that beryllium disease may take that should be emphasized. In a few cases, a worker may have one or more attacks of acute beryllium pneumonia, and after a variable period of time, with or without further beryllium exposure, may develop the chronic form of the disease. This may be a rare occurrence or may prove a serious source of chronic beryllium poisoning, since probably at least four hundred workers suffered the acute disease and doubtless many other cases were misdiagnosed as virus pneumonia.
At varying times in the clinical course of chronic beryllium intoxication, the total serum protein and globulin, liver function studies, urinary calcium, serum calcium and phosphorus, electrophoretic pattern of serum, alkaline phosphatase and urinary steroids have been reliably reported as abnormal in a varying number of cases. The interpretation of these abnormal findings is by no means certain at present. Liver function studies mentioned include bromsulfalein retention test (5 mg. per kg), cephalin flocculation test and the prothrombin time value. Where done, the punch biopsy may show hepatic pathology while liver function tests are normal. It is of interest that cephalin flocculation tests and electrophoretic patterns are abnormal in acute as well as chronic beryllium poisoning, with other findings, suggesting that these two clinical syndromes are different phases of a similar systemic reaction to a toxic insult.
There is much speculation as to the meaning of the disturbed levels-and they may be above or below normal-of serum calcium and phosphorus and alkaline phosphatase. Dr. Franklin McLean says that work in his laboratory points to direct intoxication of the process of calcification by beryllium rather than the development of beryllium rickets as previously reported. Work with beryllium7, a radioactive isotope of the element made at the Berkeley cyclotron (Crowley et al.) shows that, in tracer experiments with small laboratory animals, beryllium goes into the bone and remains there (Wilson, 1948) . It will be recalled that Dr. Leroy Gardner produced osteogenic sarcomas in rabbits with the beryllium compounds to which workers are exposed (Gardner and Heslington, 1946) . No malignancies have appeared as yet among the human victims of beryllium poisoning. Grier et al. (1949 ), Klemperer et al. (1949 and DuBois et al. (1949) , working independently, have satisfied themselves that beryllium in vitro and in vivo has an inhibitory effect on the alkaline phosphatase enzymes. Workers in Europe (Caccuri, 1940, and Aldridge, Barnes and Denz, 1949) and America (Scott, 1948) have shown in small animals that beryllium itself has direct toxic effect on the liver as well as the lung. It is premature to interpret these data. However, an attractive hypothesis-purely my own-supposes that beryllium is stored in the body, harmlessly if taken in slowly. Later, due to a change in medical status such as in pregnancy or an infection, the beryllium is mobilized and becomes pathogenic. Grier (Grier, Hood and Hoagland, 1949) and others have data to suggest beryllium displaces magnesium and the inhibition of enzymes follows with consequent widespread cellular changes, producing symptoms and signs. In leaving this subject, it is certainly fair to say that human experience and animal experimentation give strong evidence that certain beryllium compounds can produce profound changes in biological systems.
The diagnosis of beryllium poisoning rests on accurate demonstration of beryllium exposure. Spectrographic analysis will reveal beryllium in blood, urine and in biological tissue ante and post mortem in remarkably small quantities (Cholak and Hubbard, 1948) . Tuberculosis must be carefully considered. Sarcoidosis, long held by some as the diagnosis in the industrially associated disease, is ruled out by the bad prognosis, severe respiratory disability, prevalence of gastro-intestinal symptoms and absence of X-ray changes in the bone. Finally, the pathologists with whom I have worked-Dr. David Freiman at the Massachusetts General Hospital especially-consider that beryllium poisoning has a Proceeditngs of the Royal Society of Medicine 4 distinctive pathological picture. Fig. 2 shows a section made from the lung of a fatal case of acute beryllium pneumonia; next a similar example of the changes in the lung of a victim of chronic beryllium poisoning (Fig. 3) ; and, finally, an example of a case of that confusing entity, sarcoidosis (Fig. 4) . The treatment of the cases of beryllium poisoning may briefly be mentioned. Acute beryllium pneumonitis has been attended by a low mortality ever since the seriousness of the process was recognized. In cases of chronic beryllium poisoning, antibiotics, chemotherapy, B.A.L., cytochrome C, sodium citrate, have been tried, all without success. Complete rest, support of morale, and judicious use of oxygen intermittently under pressure, have made these patients more comfortable but have not altered the prognosis. Temporary reversal or at least lessening of the X-ray densities in the lung of a few cases has followed the use of ACTH or cortisone as investigative agents and this makes us wonder if ACTH may not actually dissipate for a while the cellular infiltration which prevents oxygen from reaching the tissues in this disease.
Beryllium poisoning in the United States has become an important public health problem, because of the many industries using beryllium compounds (Williams, 1948) . Mining and handling beryl ore From 1938 on, the rapid expansion of the fluorescent lamp industry accounts for most of our experience with the chronic disease. One plant using a phosphor containing about 120% beryllium reported all the cases of chronic beryllium poisoning between 1942 and 1947, but more recently other plants using a phosphor of between 2 to 3 % beryllium have reported a few cases, occurring as long as six or more years after beryllium exposure ceased. A few individuals living very close to plants processing beryl ore or manufacturing fluorescent lamps have been victims of chronic beryllium poisoning. When the facts are known concerning the amount of certain beryllium compounds loosed in the near-by air and the proximity of these patients to the operations, the appearance of these so-called neighbourhood cases ceases to be mysterious. The 6 cases noted as due to research work took place after intermittent exposure to various levels of several beryllium compounds.
It is difficult to know how accurate the figures are, especially in the series where small numbers of cases of beryllium poisoning are reported. Ignorance of the toxicity of certain beryllium compounds, failure to elicit a history of beryllium exposure by physicians not aware of industrial uses of beryllium compounds and lack in the United States of central reporting of industrial disease make these figures unreliable but definitely not exaggerated.
Since beryllium oxide is encountered in every experience of worker illness, it may be considered the aetiologic common denominator. Depending on the source and processing, the compound beryllium oxide has varying physical characteristics. This may account in part for the irregular, unpredictable sickness experience encountered in industries using beryllium compounds. The study of these physical characteristics under the electron microscope was suggested in 1947 by C. R. Williams and carried out in 1948 by Kalmus and Tenney at the Los Alamos Scientific Laboratory.
Patterns of beryllium oxide samples from United States extraction plants vary in particle sizes in one preparation from an average of 0 3 micron to another of between one and two microns. One pattern showed so-called snowball aggregates and another a pattern called fish-hook under electron microscope study at a 9,000 times magnification. f think it is easy to suppose that these two compounds might behave quite differently in gaining access to the body, in attacking cell membranes, or inciting phagocytosis once in the blood stream. In contrast to beryllium oxide, beryllium phosphate has never been reported as producing disease. The electron microscope shows gigantic particles which would not easily enter the body.
My present view is that beryllium poisoning is a systemic disease rather than an exclusively pulmonary response to toxic insult. Apparently beryllium has a direct toxic effect on certain basic enzyme systems. Pathological study shows that beryllium intoxication causes a diffuse cellular infiltration of many tissues, which usually goes on to partial granulomatous formation and later irreversible fibrous replacement of functioning tissue with resultant clinical illness, great disability in most cases and frequent death.
The vast amount of material I have been able to study and use has been graciously made available to me by many colleagues-physicists and engineers as well as physicians. I want to mention the help and encouragement I have had from the late Dr. Leroy Gardner, Dr. J. C. Aub, Mr. Manfred Bowditch, Dr. Willard Machle, Professor Philip Drinker, Dr. H. M. Van Ordstrand, and the many clinicians who have allowed me to study their patients.
